Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.450
-0.100 (-3.92%)
Nov 4, 2024, 4:00 PM EST - Market closed
MBRX's stock price has decreased by -68.04% in the past year and price targets may not have had time to catch up.
Moleculin Biotech Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$35.00
Upside
+1,328.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +1,532.65% | Apr 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $20 | Strong Buy | Maintains | $45 → $20 | +716.33% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +1,736.73% | Dec 14, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $240 | Strong Buy | Maintains | $240 | +9,695.92% | Apr 18, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $75 | Buy | Reiterates | $75 | +2,961.22% | Mar 24, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $30 → $210 | Buy | Initiates | $30 → $210 | +8,471.43% | Jul 18, 2022 |